Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection - PubMed (original) (raw)
. 1998 Jan 5;240(1):36-49.
doi: 10.1006/viro.1997.8913.
Affiliations
- PMID: 9448687
- DOI: 10.1006/viro.1997.8913
Free article
Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection
Y Huang et al. Virology. 1998.
Free article
Abstract
We previously identified a group of 10 long-term survivors (LTS) of human immunodeficiency virus type 1 (HIV-1) infection. Extensive biological analysis revealed that some of these individuals do well, at least in part, because they possess weakened or attenuated viruses. Also, previously, to determine the genotype associated with the attenuated phenotype in vivo, we characterized nef, vif, vpr, vpu, env, and LTR in our cohort of LTS. In this study, we analyzed gag and pol genes derived from eight individuals in our cohort. For each subject multiple full-length gag and pol clones were obtained for analysis. In most cases, the sequences derived from the LTS had an intact open reading frame. At the protein level, there were no discernible differences between the sequences derived from LTS and those derived from patients with AIDS. Thus, no common defect in gag and pol was found in our cohort. One individual (subject SF), however, had only Gag-defective proviral sequences (10 of 10) in his peripheral blood mononuclear cells. Furthermore, longitudinal studies of the samples collected from SF over a 2-year period showed that all p17 gag clones sequenced (24 of 24) were defective due to G-to-A hypermutations. This viral defect in Gag may provide the molecular basis for this individual's extremely low viral load and long-term asymptomatic state. These results, together with previous findings in our LTS cohort, reinforce the notion that it is unlikely that a single common viral genetic determinant accounts for the lack of disease progression in all cases. Multiple host and viral factors undoubtedly contribute to the well-being of LTS of HIV-1 infection.
Similar articles
- Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection.
Zhang L, Huang Y, Yuan H, Tuttleton S, Ho DD. Zhang L, et al. Virology. 1997 Feb 17;228(2):340-9. doi: 10.1006/viro.1996.8378. Virology. 1997. PMID: 9123841 - Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden.
Leitner T, Escanilla D, Marquina S, Wahlberg J, Broström C, Hansson HB, Uhlén M, Albert J. Leitner T, et al. Virology. 1995 May 10;209(1):136-46. doi: 10.1006/viro.1995.1237. Virology. 1995. PMID: 7747463 - Molecular approaches to AIDS vaccine development using baculovirus expression vectors.
Kang CY. Kang CY. Methods Mol Biol. 1995;39:295-315. doi: 10.1385/0-89603-272-8:295. Methods Mol Biol. 1995. PMID: 7542523 Review. No abstract available. - [Virology on AIDS and AIDS dementia complex].
Hoshino H. Hoshino H. No To Shinkei. 1997 Jan;49(1):39-49. No To Shinkei. 1997. PMID: 9027901 Review. Japanese. No abstract available.
Cited by
- Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophages.
Weiden MD, Hoshino S, Levy DN, Li Y, Kumar R, Burke SA, Dawson R, Hioe CE, Borkowsky W, Rom WN, Hoshino Y. Weiden MD, et al. PLoS One. 2014 Oct 1;9(10):e108476. doi: 10.1371/journal.pone.0108476. eCollection 2014. PLoS One. 2014. PMID: 25272020 Free PMC article. - Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.
Seager I, Travers SA, Leeson MD, Crampin AC, French N, Glynn JR, McCormack GP. Seager I, et al. AIDS Res Hum Retroviruses. 2014 Oct;30(10):975-83. doi: 10.1089/aid.2013.0240. Epub 2014 Jul 29. AIDS Res Hum Retroviruses. 2014. PMID: 24925099 Free PMC article. - HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
Salgado M, Swanson MD, Pohlmeyer CW, Buckheit RW 3rd, Wu J, Archin NM, Williams TM, Margolis DM, Siliciano RF, Garcia JV, Blankson JN. Salgado M, et al. J Virol. 2014 Mar;88(6):3340-52. doi: 10.1128/JVI.03380-13. Epub 2014 Jan 3. J Virol. 2014. PMID: 24390323 Free PMC article. - Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches.
Santa-Marta M, de Brito PM, Godinho-Santos A, Goncalves J. Santa-Marta M, et al. Front Immunol. 2013 Oct 24;4:343. doi: 10.3389/fimmu.2013.00343. Front Immunol. 2013. PMID: 24167505 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical